Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies - Stuver, Robert; Shah, Gunjan L; Korde, Neha S; Roeker, Lindsey E; Mato, Anthony R; Batlevi, Connie L; Chung, David J; Doddi, Sital; Falchi, Lorenzo; Gyurkocza, Boglarka; Hamilton, Audrey; Lin, Ya-Hui; et al. (Cancer cell, 2022)